by hleonhardt | Nov 2, 2026 | Uncategorized
Novel two-stage regenerative orthodontic technology combining RANKL, OPG, BMP9 and programmable bioelectric signaling is being developed by Leonhardt Ventures LLC for exclusive licensing to OrthodontiCell, Inc. November 1, 2026 — Leonhardt Ventures LLC, a regenerative...
by hleonhardt | Jul 12, 2023 | Uncategorized
Executive Chairman’s Best guess estimate June 2023 on portfolio assets closest to exit Note – ALL bioelectric products are based on same exact core stimulator with only slightly different signal sequence protocols. Nearly all use our stem cell homing and...
by hleonhardt | Apr 18, 2023 | Uncategorized
Dear Shareholders, Ahead of our 2023 Annual Shareholder Meeting… 1. 2022 Year End Financials https://lventuresnew.wpenginepowered.com/wp-content/uploads/2023/01/12-Dec-2022-Cal-XStarsBusinessAcceleratorInc.Financials-V1-1-17-23.pdf. 2. See 2023 budget attached...
by hleonhardt | Apr 5, 2023 | Uncategorized
Published: March 9th, 2023 Mission Viejo and Irvine, Calif., March 9th, 2023 (PRDistribution) — Dear Stakeholders, Nearly our entire portfolio of startups made great strides in progress in 2022 and are off to great start in early 2023. Here is a link to the...
by hleonhardt | Mar 31, 2023 | Uncategorized
Bioelectrics is poised to be the next frontier of medical technology, and LionHeart Health is developing therapies on several important fronts. by Susan Belknapp, Senior Writer, California Business Journal Klotho. You may not have heard of it, but this protein is...
by hleonhardt | Mar 30, 2023 | Uncategorized
NEWS PROVIDED BY Leonhardt Ventures LLC 30th Mar, 2023, 9:00am PT Mission Viejo, CA , March 30th, 2023 /PRDistribution/ — Leonhardt Ventures LLC announces today that Brian Lasater has joined earlier this year the firm as Chief Technology Officer. In this role,...
